A new post-approval study of over 1.6 million Danish women has shown that the quadrivalent human papillomavirus (HPV) vaccine poses no increased risk of blood clots at any time within 42 days of receiving the immunization. As a result A causal relationship between HPV (type 16) and some cases mouth, tongue, and throat cancers has also been demonstrated in men.

READ FULL ARTICLE Curated publisher From Forbes